Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Modern methods for assessing the drugs used in the chemotherapy of mycobacterial disease.

× No keyword cloud information.

8 in total

Review 1. New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development.

Authors: Jossy van den Boogaard; Gibson S Kibiki; Elton R Kisanga; Martin J Boeree; Rob E Aarnoutse
Journal: Antimicrob Agents Chemother Date: 2008-12-15 Impact factor: 5.191

2. Myeloperoxidase exerts microbicidal activity against Mycobacterium tuberculosis.

Authors: V Borelli; E Banfi; M G Perrotta; G Zabucchi
Journal: Infect Immun Date: 1999-08 Impact factor: 3.441

3. Assessment of the Efficacy of New Anti-Tuberculosis Drugs.

Authors: Denis A Mitchison; Geraint R Davies
Journal: Open Infect Dis J Date: 2008-12

4. Serial counts of Mycobacterium tuberculosis in sputum as surrogate markers of the sterilising activity of rifampicin and pyrazinamide in treating pulmonary tuberculosis.

Authors: R Brindle; J Odhiambo; D Mitchison
Journal: BMC Pulm Med Date: 2001 Impact factor: 3.317

5. Systematic measurement of combination-drug landscapes to predict in vivo treatment outcomes for tuberculosis.

Authors: Jonah Larkins-Ford; Talia Greenstein; Nhi Van; Yonatan N Degefu; Michaela C Olson; Artem Sokolov; Bree B Aldridge
Journal: Cell Syst Date: 2021-08-31 Impact factor: 10.304

6. Design principles to assemble drug combinations for effective tuberculosis therapy using interpretable pairwise drug response measurements.

Authors: Jonah Larkins-Ford; Yonatan N Degefu; Nhi Van; Artem Sokolov; Bree B Aldridge
Journal: Cell Rep Med Date: 2022-09-08

7. An evaluation of culture results during treatment for tuberculosis as surrogate endpoints for treatment failure and relapse.

Authors: Patrick P J Phillips; Katherine Fielding; Andrew J Nunn
Journal: PLoS One Date: 2013-05-08 Impact factor: 3.240

8. Transcriptomic Signatures Predict Regulators of Drug Synergy and Clinical Regimen Efficacy against Tuberculosis.

Authors: Shuyi Ma; Suraj Jaipalli; Jonah Larkins-Ford; Jenny Lohmiller; Bree B Aldridge; David R Sherman; Sriram Chandrasekaran
Journal: mBio Date: 2019-11-12 Impact factor: 7.867

8 in total